Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic ...

“Expression of one HIF-regulated vasoactive gene, ANGPTL4, cooperates with VEGF to promote the development of choroidal ...

Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...

AVT06/AVT29 is a recombinant fusion protein and a biosimilar candidate to Eylea ® (aflibercept) 2 mg and 8 mg dose, which binds vascular endothelial growth factors (VEGF), inhibiting the binding and ...

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular ...

Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline results ...